Skip to main content
Springer Nature Link
Log in

Successful treatment of CANOMAD with IVIg and rituximab

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Willison HJ, O’Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, Fuhr P et al (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124(Pt 10):1968–1977

    Article  PubMed  CAS  Google Scholar 

  2. Eurelings M, Ang CW, Notermans NC, Van Doorn PA, Jacobs BC, Van den Berg LH (2001) Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 57(10):1909–1912

    Article  PubMed  CAS  Google Scholar 

  3. Susuki K, Yuki N, Hirata K (2001) Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody. J Neuroimmunol 112(1–2):181–187

    Article  PubMed  CAS  Google Scholar 

  4. Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, Mcelroy B (2009) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65(3):286–293

    Article  PubMed  CAS  Google Scholar 

  5. Delmont E, Jeandel PY, Benaïm C, Rosenthal E, Fuzibet JG, Desnuelle C (2011) Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies. J Neurol 258(9):1717–1719

    Article  PubMed  Google Scholar 

  6. Niermeijer JMF, Eurelings M, Lokhorst HL, Van Der Pol W-L, Franssen H, Wokke JHJ, Notermans NC (2009) Rituximab for polyneuropathy with IgM monoclonal gammopathy. J Neurol Neurosurg Psychiatr 80(9):1036–1039

    Article  PubMed  CAS  Google Scholar 

  7. Delmont E, Jeandel PY, Hubert AM, Marcq L, Boucraut J, Desnuelle C (2010) Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol 257(4):655–657

    Article  PubMed  Google Scholar 

  8. Siddiqui K, Cahalane E, Keogan M, Hardiman O (2003) Chronic ataxic neuropathy with cold agglutinins: atypical phenotype and response to anti-CD20 antibodies. Neurology 61(9):1307–1308

    Article  PubMed  CAS  Google Scholar 

  9. Joint Task Force of the EFNS and the PNS (2010) European federation of neurological societies/peripheral nerve society guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European federation of neurological societies and the peripheral nerve society–first revision. J Peripher Nerv Syst 15(3):185–195

    Article  Google Scholar 

  10. Benedetti L, Briani C, Franciotta D, Carpo M, Padua L, Zara G, Zambello R et al (2008) Long-term effect of rituximab in anti-mag polyneuropathy. Neurology 71(21):1742–1744

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standard

Written informed consent was obtained from the patient for publication of this case report.

Author information

Authors and Affiliations

  1. Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

    Wolfgang N. Löscher, Monika Wallnöfer, Julia V. Wanschitz & Gerhard Luef

  2. Department of Neurology, Kardinal Schwarzenberg Hospital, Schwarzach, Austria

    Alexander Woertz

Authors
  1. Wolfgang N. Löscher
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Alexander Woertz
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Monika Wallnöfer
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Julia V. Wanschitz
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Gerhard Luef
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Wolfgang N. Löscher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Löscher, W.N., Woertz, A., Wallnöfer, M. et al. Successful treatment of CANOMAD with IVIg and rituximab. J Neurol 260, 1168–1170 (2013). https://doi.org/10.1007/s00415-013-6867-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6867-5

Keywords